Significance	NN	significance NN PennPOS
of	IN	of pp-f NUPOS
elevated	JJ	elevated JJ PennPOS
procollagen-III-peptide	NN	procollagen-III-peptide NN PennPOS
and	CC	and cc NUPOS
transforming-growth-factor-beta	NN	transforming-growth-factor-beta NN PennPOS
levels	NNS	level NNS PennPOS
of	IN	of pp-f NUPOS
bronchoalveolar	JJ	bronchoalveolar JJ PennPOS
lavage	NN	lavage NN PennPOS
fluids	NNS	fluid NNS PennPOS
from	IN	from pp NUPOS
idiopathic	JJ	idiopathic JJ PennPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
patients	NNS	patient NNS PennPOS
.	.	. . NUPOS

Although	IN	although cs NUPOS
both	DT	both d NUPOS
procollagen	NN	procollagen NN PennPOS
III	CD	III crd NUPOS
aminopeptide	NN	aminopeptide NN PennPOS
(	(	( ( NUPOS
P-III-P	NN	P-III-P NN PennPOS
)	)	) ) NUPOS
and	CC	and cc NUPOS
transforming-growth-factor-beta	NN	transforming-growth-factor-beta NN PennPOS
(	(	( ( NUPOS
TGF-beta	NN	TGF-beta NN PennPOS
)	)	) ) NUPOS
are	VBP	be vbb NUPOS
reported	VBN	report VBN PennPOS
to	TO	to p-acp NUPOS
be	VB	be vbi NUPOS
present	JJ	present JJ PennPOS
in	IN	in IN PennPOS
lung	NN	lung NN PennPOS
tissue	NN	tissue NN PennPOS
and/or	CC	and/or CC PennPOS
elevated	JJ	elevated JJ PennPOS
in	IN	in IN PennPOS
bronchoalveolar	JJ	bronchoalveolar JJ PennPOS
lavage	NN	lavage NN PennPOS
fluid	NN	fluid NN PennPOS
(	(	( ( NUPOS
BALF	NN	BALF NN PennPOS
)	)	) ) NUPOS
from	IN	from pp NUPOS
idiopathic	JJ	idiopathic JJ PennPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
(	(	( ( NUPOS
IPF	NN	IPF NN PennPOS
)	)	) ) NUPOS
patients	NNS	patient NNS PennPOS
,	,	, , NUPOS
we	PRP	we pns12 NUPOS
have	VBP	have vhb NUPOS
little	JJ	little JJ PennPOS
knowledge	NN	knowledge NN PennPOS
concerning	VBG	concern VBG PennPOS
the	DT	the dt NUPOS
clinical	JJ	clinical JJ PennPOS
significance	NN	significance NN PennPOS
of	IN	of pp-f NUPOS
elevated	JJ	elevated JJ PennPOS
P-III-P	NN	P-III-P NN PennPOS
and	CC	and cc NUPOS
TGF-beta	NN	TGF-beta NN PennPOS
levels	NNS	level NNS PennPOS
in	IN	in IN PennPOS
BALF	NN	BALF NN PennPOS
.	.	. . NUPOS

Using	VBG	use VBG PennPOS
a	DT	a dt NUPOS
radioimmunoassay	NN	radioimmunoassay NN PennPOS
,	,	, , NUPOS
we	PRP	we pns12 NUPOS
measured	VBD	measure VBD PennPOS
P-III-P	NN	P-III-P NN PennPOS
and	CC	and cc NUPOS
TGF-beta	NN	TGF-beta NN PennPOS
in	IN	in IN PennPOS
BALF	NN	BALF NN PennPOS
from	IN	from pp NUPOS
48	CD	48 CD PennPOS
IPF	NN	IPF NN PennPOS
patients	NNS	patient NNS PennPOS
(	(	( ( NUPOS
16F	NN	16F NN PennPOS
and	CC	and cc NUPOS
32M	NN	32M NN PennPOS
,	,	, , NUPOS
59	CD	59 CD PennPOS
+	CC	+ CC PennPOS
/	:	/ : NUPOS
-	:	- : NUPOS
2	CD	2 crd NUPOS
years	NNS	year NNS PennPOS
,	,	, , NUPOS
mean	NN	mean NN PennPOS
+	CC	+ CC PennPOS
/	:	/ : NUPOS
-	:	- : NUPOS
S.E.	NN	S.E. NN PennPOS
)	)	) ) NUPOS
who	WP	who q-crq NUPOS
received	VBD	receive VBD PennPOS
BAL	NN	bal NN PennPOS
in	IN	in IN PennPOS
our	PRP$	our po12 NUPOS
clinic	NN	clinic NN PennPOS
over	IN	over IN PennPOS
the	DT	the dt NUPOS
past	JJ	past JJ PennPOS
13	CD	13 crd NUPOS
years	NNS	year NNS PennPOS
before	IN	before c-acp NUPOS
glucocorticosteroid	NN	glucocorticosteroid NN PennPOS
treatment	NN	treatment NN PennPOS
.	.	. . NUPOS

Among	IN	among IN PennPOS
them	PRP	they pno32 NUPOS
,	,	, , NUPOS
we	PRP	we pns12 NUPOS
could	MD	can vmd NUPOS
detect	VB	detect VBP PennPOS
a	DT	a dt NUPOS
significant	JJ	significant JJ PennPOS
amount	NN	amount NN PennPOS
of	IN	of pp-f NUPOS
P-III-P	NN	P-III-P NN PennPOS
(	(	( ( NUPOS
2.2	CD	2.2 CD PennPOS
+	CC	+ CC PennPOS
/	:	/ : NUPOS
-	:	- : NUPOS
1.0	CD	1.0 CD PennPOS
U/ml	NN	U/ml NN PennPOS
;	:	; : NUPOS
range	NN	range NN PennPOS
0.03	CD	0.03 CD PennPOS
to	TO	to p-acp NUPOS
16.5	CD	16.5 CD PennPOS
U/ml	NN	U/ml NN PennPOS
)	)	) ) NUPOS
in	IN	in IN PennPOS
BALF	NN	BALF NN PennPOS
in	IN	in IN PennPOS
18	CD	18 crd NUPOS
of	IN	of pp-f NUPOS
the	DT	the dt NUPOS
patients	NNS	patient NNS PennPOS
(	(	( ( NUPOS
5F	NN	5F NN PennPOS
and	CC	and cc NUPOS
13M	NN	13M NN PennPOS
,	,	, , NUPOS
58	CD	58 crd NUPOS
+	CC	+ CC PennPOS
/	:	/ : NUPOS
-	:	- : NUPOS
3	CD	3 crd NUPOS
years	NNS	year NNS PennPOS
)	)	) ) NUPOS
(	(	( ( NUPOS
group	NN	group NN PennPOS
B	NN	b NN PennPOS
)	)	) ) NUPOS
.	.	. . NUPOS

but	CC	but cc-acp NUPOS
not	RB	not xx NUPOS
(	(	( ( NUPOS
0.03	CD	0.03 CD PennPOS
U/ml	NN	U/ml NN PennPOS
or	CC	or cc NUPOS
less	JJR	little JJR PennPOS
)	)	) ) NUPOS
in	IN	in IN PennPOS
the	DT	the dt NUPOS
other	JJ	other JJ PennPOS
30	CD	30 crd NUPOS
patients	NNS	patient NNS PennPOS
(	(	( ( NUPOS
11F	NN	11F NN PennPOS
and	CC	and cc NUPOS
19M	NN	19M NN PennPOS
,	,	, , NUPOS
59	CD	59 CD PennPOS
+	CC	+ CC PennPOS
/	:	/ : NUPOS
-	:	- : NUPOS
2	CD	2 crd NUPOS
years	NNS	year NNS PennPOS
)	)	) ) NUPOS
(	(	( ( NUPOS
group	NN	group NN PennPOS
A	NN	a NN PennPOS
)	)	) ) NUPOS
.	.	. . NUPOS

Lymphocyte	NN	lymphocyte NN PennPOS
(	(	( ( NUPOS
%	NN	% NN PennPOS
)	)	) ) NUPOS
and	CC	and cc NUPOS
basophil	NN	basophil NN PennPOS
(	(	( ( NUPOS
%	NN	% NN PennPOS
)	)	) ) NUPOS
in	IN	in IN PennPOS
BALF	NN	BALF NN PennPOS
from	IN	from pp NUPOS
group	NN	group NN PennPOS
B	NN	b NN PennPOS
was	VBD	be vbd NUPOS
much	RB	much RB PennPOS
larger	JJR	large JJR PennPOS
than	IN	than cs NUPOS
that	DT	that d NUPOS
from	IN	from pp NUPOS
group	NN	group NN PennPOS
A	NN	a NN PennPOS
(	(	( ( NUPOS
33	CD	33 CD PennPOS
%	NN	% NN PennPOS
vs.	CC	vs. CC PennPOS
8	CD	8 crd NUPOS
%	NN	% NN PennPOS
,	,	, , NUPOS
p	NN	p NN PennPOS
<	JJR	< JJR PennPOS
0.01	CD	0.01 CD PennPOS
)	)	) ) NUPOS
.	.	. . NUPOS

Group	NN	group NN PennPOS
B	NN	b NN PennPOS
showed	VBD	show VBN PennPOS
a	DT	a dt NUPOS
longer	RBR	long av-jc NUPOS
duration	NN	duration NN PennPOS
of	IN	of pp-f NUPOS
onset	NN	onset NN PennPOS
to	TO	to p-acp NUPOS
BAL	NN	bal NN PennPOS
(	(	( ( NUPOS
36	CD	36 CD PennPOS
months	NNS	month NNS PennPOS
vs.	CC	vs. CC PennPOS
23	CD	23 crd NUPOS
months	NNS	month NNS PennPOS
,	,	, , NUPOS
p	NN	p NN PennPOS
<	JJR	< JJR PennPOS
0.05	CD	0.05 CD PennPOS
)	)	) ) NUPOS
.	.	. . NUPOS

TGF-beta	NN	TGF-beta NN PennPOS
levels	NNS	level NNS PennPOS
were	VBD	be vbd NUPOS
obtained	VBN	obtain VBN PennPOS
using	VBG	use VBG PennPOS
an	DT	a dt NUPOS
ELISA	NN	elisa NN PennPOS
system	NN	system NN PennPOS
kit	NN	kit NN PennPOS
from	IN	from pp NUPOS
the	DT	the dt NUPOS
same	JJ	same JJ PennPOS
BALF	NN	BALF NN PennPOS
samples	NNS	sample NNS PennPOS
.	.	. . NUPOS

TGF-beta	NN	TGF-beta NN PennPOS
was	VBD	be vbd NUPOS
not	RB	not xx NUPOS
detected	VBN	detect VBN PennPOS
in	IN	in IN PennPOS
10	CD	10 crd NUPOS
patients	NNS	patient NNS PennPOS
(	(	( ( NUPOS
100	CD	100 crd NUPOS
pg/ml	NN	pg/ml NN PennPOS
or	CC	or cc NUPOS
less	JJR	little JJR PennPOS
)	)	) ) NUPOS
(	(	( ( NUPOS
3F	NN	3F NN PennPOS
and	CC	and cc NUPOS
7M	NN	7M NN PennPOS
,	,	, , NUPOS
59	CD	59 CD PennPOS
+	CC	+ CC PennPOS
/	:	/ : NUPOS
-	:	- : NUPOS
4	CD	4 crd NUPOS
years	NNS	year NNS PennPOS
)	)	) ) NUPOS
(	(	( ( NUPOS
group	NN	group NN PennPOS
I	CD	i crd NUPOS
)	)	) ) NUPOS
,	,	, , NUPOS
while	IN	while cs NUPOS
the	DT	the dt NUPOS
remaining	VBG	remain VBG PennPOS
38	CD	38 crd NUPOS
patients	NNS	patient NNS PennPOS
showed	VBD	show VBN PennPOS
a	DT	a dt NUPOS
significant	JJ	significant JJ PennPOS
amount	NN	amount NN PennPOS
of	IN	of pp-f NUPOS
TGF-beta	NN	TGF-beta NN PennPOS
(	(	( ( NUPOS
329	CD	329 crd NUPOS
+	CC	+ CC PennPOS
/	:	/ : NUPOS
-	:	- : NUPOS
44	CD	44 crd NUPOS
pg/ml	NN	pg/ml NN PennPOS
,	,	, , NUPOS
range	NN	range NN PennPOS
100	CD	100 crd NUPOS
to	TO	to p-acp NUPOS
1,360	CD	1,360 CD PennPOS
pg/ml	NN	pg/ml NN PennPOS
)	)	) ) NUPOS
.	.	. . NUPOS

The	DT	the dt NUPOS
latter	JJ	latter JJ PennPOS
patients	NNS	patient NNS PennPOS
were	VBD	be vbd NUPOS
further	JJ	further JJ PennPOS
divided	VBN	divide VBN PennPOS
into	IN	into pp NUPOS
two	CD	two crd NUPOS
groups	NNS	group NNS PennPOS
;	:	; : NUPOS
group	NN	group NN PennPOS
II	CD	II crd NUPOS
100	CD	100 crd NUPOS
to	TO	to p-acp NUPOS
300	CD	300 CD PennPOS
pg/ml	NN	pg/ml NN PennPOS
(	(	( ( NUPOS
10F	NN	10F NN PennPOS
and	CC	and cc NUPOS
14M	NN	14M NN PennPOS
,	,	, , NUPOS
56	CD	56 CD PennPOS
+	CC	+ CC PennPOS
/	:	/ : NUPOS
-	:	- : NUPOS
3	CD	3 crd NUPOS
years	NNS	year NNS PennPOS
)	)	) ) NUPOS
and	CC	and cc NUPOS
group	NN	group NN PennPOS
III	CD	III crd NUPOS
350	CD	350 CD PennPOS
or	CC	or cc NUPOS
more	JJR	many JJR PennPOS
(	(	( ( NUPOS
3F	NN	3F NN PennPOS
and	CC	and cc NUPOS
11M	NN	11M NN PennPOS
,	,	, , NUPOS
63	CD	63 crd NUPOS
+	CC	+ CC PennPOS
/	:	/ : NUPOS
-	:	- : NUPOS
2	CD	2 crd NUPOS
years	NNS	year NNS PennPOS
)	)	) ) NUPOS
.	.	. . NUPOS

Group	NNP	group NN PennPOS
III	NNP	iii NN PennPOS
showed	VBD	show VBN PennPOS
significantly	RB	significant av-j NUPOS
better	JJR	good jc NUPOS
values	NNS	value NNS PennPOS
in	IN	in IN PennPOS
PaO2	NN	PaO2 NN PennPOS
,	,	, , NUPOS
Aa-DO2	NN	Aa-DO2 NN PennPOS
,	,	, , NUPOS
%	NN	% NN PennPOS
VC	NN	VC NN PennPOS
and	CC	and cc NUPOS
%	NN	% NN PennPOS
DLco	NN	DLco NN PennPOS
,	,	, , NUPOS
and	CC	and cc NUPOS
smaller	JJR	small JJR PennPOS
percentage	NN	percentage NN PennPOS
of	IN	of pp-f NUPOS
basophils	NNS	basophil NNS PennPOS
in	IN	in IN PennPOS
BALF	NN	BALF NN PennPOS
than	IN	than cs NUPOS
did	VBD	do vdd NUPOS
groups	NNS	group NNS PennPOS
I	PRP	i pns11 NUPOS
and/or	CC	and/or CC PennPOS
II	CD	II crd NUPOS
,	,	, , NUPOS
whereas	IN	whereas cs NUPOS
survival	NN	survival NN PennPOS
after	IN	after c-acp NUPOS
BAL	NN	bal NN PennPOS
in	IN	in IN PennPOS
group	NN	group NN PennPOS
III	CD	III crd NUPOS
was	VBD	be vbd NUPOS
significantly	RB	significant av-j NUPOS
shorter	JJR	short JJR PennPOS
than	IN	than cs NUPOS
in	IN	in IN PennPOS
group	NN	group NN PennPOS
I	CD	i crd NUPOS
(	(	( ( NUPOS
31	CD	31 crd NUPOS
vs.	CC	vs. CC PennPOS
19	CD	19 CD PennPOS
months	NNS	month NNS PennPOS
,	,	, , NUPOS
p	NN	p NN PennPOS
<	JJR	< JJR PennPOS
0.05	CD	0.05 CD PennPOS
)	)	) ) NUPOS
.	.	. . NUPOS

There	EX	there pc-acp NUPOS
was	VBD	be vbd NUPOS
no	DT	no dx NUPOS
significant	JJ	significant JJ PennPOS
relationship	NN	relationship NN PennPOS
between	IN	between IN PennPOS
P-III-P	NN	P-III-P NN PennPOS
and	CC	and cc NUPOS
TGF-beta	NN	TGF-beta NN PennPOS
levels	NNS	level NNS PennPOS
in	IN	in IN PennPOS
BALF	NN	BALF NN PennPOS
.	.	. . NUPOS

These	DT	these d NUPOS
findings	NNS	finding n2 NUPOS
suggest	VBP	suggest VBP PennPOS
that	IN	that cst NUPOS
elevated	JJ	elevated JJ PennPOS
P-III-P	NN	P-III-P NN PennPOS
level	NN	level NN PennPOS
is	VBZ	be vbz NUPOS
accompanied	VBN	accompany VBN PennPOS
by	IN	by IN PennPOS
an	DT	a dt NUPOS
increase	NN	increase NN PennPOS
in	IN	in IN PennPOS
lymphocyte	NN	lymphocyte NN PennPOS
population	NN	population NN PennPOS
in	IN	in IN PennPOS
BALF	NN	BALF NN PennPOS
from	IN	from pp NUPOS
IPF	NN	IPF NN PennPOS
patients	NNS	patient NNS PennPOS
,	,	, , NUPOS
resulting	VBG	result VBG PennPOS
in	IN	in IN PennPOS
a	DT	a dt NUPOS
longer	RBR	long av-jc NUPOS
duration	NN	duration NN PennPOS
of	IN	of pp-f NUPOS
the	DT	the dt NUPOS
disease	NN	disease NN PennPOS
,	,	, , NUPOS
while	IN	while cs NUPOS
elevated	JJ	elevated JJ PennPOS
TGF-beta	NN	TGF-beta NN PennPOS
level	NN	level NN PennPOS
reflects	VBZ	reflect VBZ PennPOS
alveolar	JJ	alveolar JJ PennPOS
inflammation	NN	inflammation NN PennPOS
at	IN	at pp NUPOS
an	DT	a dt NUPOS
earlier	JJR	early JJR PennPOS
stage	NN	stage NN PennPOS
of	IN	of pp-f NUPOS
the	DT	the dt NUPOS
disease	NN	disease NN PennPOS
which	WDT	which r-crq NUPOS
induces	VBZ	induce VBZ PennPOS
a	DT	a dt NUPOS
progression	NN	progression NN PennPOS
of	IN	of pp-f NUPOS
the	DT	the dt NUPOS
disease	NN	disease NN PennPOS
,	,	, , NUPOS
resulting	VBG	result VBG PennPOS
in	IN	in IN PennPOS
a	DT	a dt NUPOS
shorter	JJR	short JJR PennPOS
survival	NN	survival NN PennPOS
in	IN	in IN PennPOS
IPF	NN	IPF NN PennPOS
patients	NNS	patient NNS PennPOS
.	.	. . NUPOS

